Metabolic syndrome and hemorrhagic stroke among symptomatic CCMs in the Mexican Hispanic Population

Cerebral cavernous malformations (CCMs) are neurological disorders that make individuals more susceptible to hemorrhagic stroke. The Mexican-Hispanic population has a higher prevalence of both CCMs and metabolic syndrome (MetS), which is also associated with hemorrhagic stroke. A study was conducted with 184 Mexican-Hispanic CCM subjects and age- and sex-matched Hispanic and non-Hispanic white controls. The CCM cohort had a higher proportion of epilepsy and hemorrhagic stroke but a lower proportion of MetS. Higher blood pressure and fasting glucose levels were observed in the CCM cohort. MetS and epilepsy were associated with increased odds of hemorrhagic stroke among elderly CCM patients, and increased systolic blood pressure was significantly linked to increased odds of hemorrhagic stroke in the CCM cohort. To minimize the risk of hemorrhagic stroke, it is important to manage blood pressure and comorbidities like MetS and epilepsy in CCM patients, particularly those older than 50.

[1]  A. Hazzou,et al.  Stroke-related early seizures: clinical and neurophysiological study in a sample of Egyptian population , 2023, The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.

[2]  R. Mastrocola,et al.  Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress , 2022, International journal of molecular sciences.

[3]  A. Dwivedi,et al.  Association of Exposure to Phthalate Metabolites With Sex Hormones, Obesity, and Metabolic Syndrome in US Women , 2022, JAMA network open.

[4]  A. Dwivedi How to write statistical analysis section in medical research , 2022, Journal of Investigative Medicine.

[5]  Zhanghua Wu,et al.  Five-year symptomatic hemorrhage risk of untreated brainstem cavernous malformations in a prospective cohort , 2022, Neurosurgical Review.

[6]  Bixia Chen,et al.  Cerebral cavernous malformations do not fall in the spectrum of PIK3CA-related overgrowth , 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

[7]  A. Nouet,et al.  Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations. , 2021, The New England journal of medicine.

[8]  A. Perrelli,et al.  Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease. , 2021, Free radical biology & medicine.

[9]  J. Dekker,et al.  Metabolic syndrome in patients with first-ever ischemic stroke: prevalence and association with coronary heart disease , 2021, Scientific Reports.

[10]  M. Koepp,et al.  Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management , 2021, Drugs & Aging.

[11]  Bixia Chen,et al.  Modifiable Cardiovascular Risk Factors in Patients With Sporadic Cerebral Cavernous Malformations , 2021, Stroke.

[12]  P. S. Idiculla,et al.  Cerebral Cavernous Malformations, Developmental Venous Anomaly, and Its Coexistence: A Review , 2020, European Neurology.

[13]  Navkiran K. Shokar,et al.  The association between metabolic syndrome and Hepatitis C virus infection in the United States , 2020, Cancer Causes & Control.

[14]  A. Perrelli,et al.  Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations , 2020, Antioxidants.

[15]  Rakesh Shukla,et al.  Evidence-based statistical analysis and methods in biomedical research (SAMBR) checklists according to design features. , 2019, Cancer reports.

[16]  J. Schmitt,et al.  Metabolic Changes of Brain Developmental Venous Anomalies on 18F-FDG-PET. , 2019, Academic radiology.

[17]  Jun Zhang,et al.  Recent advances in cerebral cavernous malformation research , 2018, Vessel plus.

[18]  Hualiang Lin,et al.  Is Metabolic Syndrome Associated with the Risk of Recurrent Stroke: A Meta-Analysis of Cohort Studies. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[19]  G. Lanzino,et al.  Prevalence of cerebral cavernous malformations associated with developmental venous anomalies increases with age , 2017, Child's Nervous System.

[20]  A. Dwivedi,et al.  Moderate and Severe Blood Pressure Elevation Associated with Stroke in the Mexican Hispanic Population , 2017, Health.

[21]  N. Sarrafzadegan,et al.  Metabolic Syndrome and the Risk of Ischemic Stroke. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[22]  S. Retta,et al.  Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin , 2016, The international journal of biochemistry & cell biology.

[23]  M. Larvie,et al.  Quantitative Analysis of Metabolic Abnormality Associated with Brain Developmental Venous Anomalies , 2016, Cureus.

[24]  L. Morrison,et al.  Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1 , 2016, Free radical biology & medicine.

[25]  G. Lip,et al.  Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic. , 2015, Heart rhythm.

[26]  M. Larvie,et al.  Brain Metabolic Abnormalities Associated with Developmental Venous Anomalies , 2015, American Journal of Neuroradiology.

[27]  I. Piña,et al.  Status of Cardiovascular Disease and Stroke in Hispanics/Latinos in the United States: A Science Advisory From the American Heart Association , 2014, Circulation.

[28]  Jun Zhang,et al.  Metabolic syndrome associated with ischemic stroke among the Mexican Hispanic population in the El Paso/US-Mexico border region. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[29]  E. Araki,et al.  Prevalence of metabolic syndrome in stroke patients: a prospective multicenter study in Japan , 2014, Acute medicine & surgery.

[30]  C. McCulloch,et al.  Association of Cardiovascular Risk Factors with Disease Severity in Cerebral Cavernous Malformation Type 1 Subjects with the Common Hispanic Mutation , 2013, Cerebrovascular Diseases.

[31]  C. Rosen,et al.  Age and the Metabolic Syndrome as Risk Factors for Ischemic Stroke: Improving Preclinical Models of Ischemic Stroke , 2012, The Yale journal of biology and medicine.

[32]  Kuo-Hsuan Chang,et al.  Effect of pre-diabetes on future risk of stroke: meta-analysis , 2012, BMJ : British Medical Journal.

[33]  Lawrence Joseph,et al.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[34]  L. Morrison,et al.  Familial versus Sporadic Cavernous Malformations: Differences in Developmental Venous Anomaly Association and Lesion Phenotype , 2010, American Journal of Neuroradiology.

[35]  D. Rigamonti,et al.  Cavernous malformations: natural history, diagnosis and treatment , 2009, Nature Reviews Neurology.

[36]  M. Inoue,et al.  The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study , 2009, Hypertension Research.

[37]  L. Morgenstern,et al.  Stroke in minorities. , 2008, Neurologic clinics.

[38]  K. Sheikh Metabolic syndrome and stroke. , 2008, Stroke.

[39]  K. Yamagishi,et al.  Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke among Middle-Aged Japanese , 2008, Hypertension Research.

[40]  A. Unger,et al.  Diabetes, hypertension, and dyslipidemia in Mexican Americans and non-Hispanic whites. , 2006, American journal of preventive medicine.

[41]  P. Rothwell Prevention of Stroke in Patients with Diabetes mellitus and the Metabolic Syndrome , 2005, Cerebrovascular Diseases.

[42]  B. Crain,et al.  Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations , 2001, Journal of neurology, neurosurgery, and psychiatry.

[43]  H. Dietz,et al.  Cloning of the murine Krit1 cDNA reveals novel mammalian 5' coding exons. , 2000, Genomics.

[44]  Crone,et al.  The natural history of cavernous malformations: a prospective study of 68 patients , 1999, Neurosurgery.

[45]  R. Scott,et al.  Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. , 1998, Human molecular genetics.

[46]  J. Weber,et al.  Refined localization of the cerebral cavernous malformation gene (CCM1) to a 4-cM interval of chromosome 7q contained in a well-defined YAC contig. , 1995, Genome research.

[47]  A. Elster,et al.  An analysis of the natural history of cavernous angiomas. , 1991, Journal of neurosurgery.

[48]  M. Hadley,et al.  Cerebral cavernous malformations. Incidence and familial occurrence. , 1988, The New England journal of medicine.

[49]  M. Hadley,et al.  The MRI appearance of cavernous malformations (angiomas). , 1987, Journal of neurosurgery.

[50]  J. Zabramski,et al.  Developmental venous anomalies. , 2017, Handbook of clinical neurology.

[51]  S. You,et al.  Impact of metabolic syndrome components on incident stroke subtypes: a Chinese cohort study , 2014, Journal of Human Hypertension.

[52]  B. Rilliet,et al.  [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. , 1989, Neuro-Chirurgie.